The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Authors
Keywords
-
Journal
HEADACHE
Volume 61, Issue 7, Pages 1021-1039
Publisher
Wiley
Online
2021-06-23
DOI
10.1111/head.14153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study
- (2020) Anker Stubberud et al. HEADACHE
- Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II
- (2020) David W. Dodick et al. HEADACHE
- Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
- (2020) Jessica Ailani et al. HEADACHE
- Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
- (2020) Dawn C. Buse et al. JOURNAL OF HEADACHE AND PAIN
- Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response
- (2020) Steven C Marcus et al. CEPHALALGIA
- Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
- (2020) Stewart J Tepper et al. CEPHALALGIA
- Dual Therapy With Anti‐CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
- (2020) Lanfranco Pellesi et al. HEADACHE
- The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: A systematic review
- (2020) Michal Stanak et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study
- (2020) Michael J. Marmura et al. Frontiers in Neurology
- Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
- (2020) Hans-Christoph Diener et al. CEPHALALGIA
- Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache
- (2020) Jill C Rau et al. CEPHALALGIA
- Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache
- (2020) Edita Navratilova et al. CEPHALALGIA
- Monoclonal antibodies as a preventive therapy for migraine: A meta-analysis
- (2020) Yousef Waleed Alasad et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Acceptance and Commitment Therapy for Primary Headache Sufferers: A Randomized Controlled Trial of Efficacy
- (2020) Vasilis S. Vasiliou et al. JOURNAL OF PAIN
- Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
- (2020) Elizabeth Leroux et al. ADVANCES IN THERAPY
- Differential medication overuse risk of novel anti-migraine therapeutics
- (2020) Chonlawan Saengjaroentham et al. BRAIN
- Real-world effectiveness and tolerability of erenumab: A retrospective cohort study
- (2020) Saad Kanaan et al. CEPHALALGIA
- Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
- (2020) Gary Berman et al. HEADACHE
- Targeting CGRP in migraine: a matter of choice and dose
- (2020) Linda Al-Hassany et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
- (2020) Peter J Goadsby et al. LANCET NEUROLOGY
- Mindfulness as an add-on treatment for patients with chronic migraine and medication overuse: a preliminary analysis
- (2020) Emanuela Sansone et al. NEUROLOGICAL SCIENCES
- Quality improvement in neurology
- (2020) Matthew S. Robbins et al. NEUROLOGY
- LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY
- (2020) Peter J. Goadsby et al. NEUROLOGY
- Remote electrical neuromodulation for acute treatment of migraine in adolescents
- (2020) Andrew D. Hershey et al. HEADACHE
- Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
- (2020) Robert Croop et al. LANCET
- Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine
- (2020) Rebecca Erwin Wells et al. JAMA Internal Medicine
- ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study
- (2019) Licia Grazzi et al. NEUROLOGICAL SCIENCES
- Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
- (2019) Hans-Christoph Diener et al. CEPHALALGIA
- Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
- (2019) Peter J Goadsby et al. BRAIN
- Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
- (2019) David Yarnitsky et al. HEADACHE
- Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
- (2019) Virginia L. Stauffer et al. HEADACHE
- Physician and patient preferences for dosing options in migraine prevention
- (2019) Robert Cowan et al. JOURNAL OF HEADACHE AND PAIN
- Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
- (2019) David W Dodick et al. CEPHALALGIA
- Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
- (2019) Bianca Raffaelli et al. JOURNAL OF HEADACHE AND PAIN
- Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications
- (2019) Alan M. Rapoport et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
- (2019) Robert Croop et al. LANCET
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Mindfulness‐Based Cognitive Therapy for Migraine Reduce Migraine‐Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial
- (2019) Elizabeth K. Seng et al. HEADACHE
- Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
- (2019) Messoud Ashina et al. CEPHALALGIA
- SEEDS for success: Lifestyle management in migraine
- (2019) J. ROBBLEE et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
- (2019) Alan M. Rapoport et al. HEADACHE
- Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
- (2019) Richard B. Lipton et al. HEADACHE
- Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
- (2019) Richard B. Lipton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular safety of erenumab for migraine prevention
- (2019) David Kudrow et al. NEUROLOGY
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
- (2018) Cristina Tassorelli et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
- (2018) Amaal J Starling et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study
- (2018) Samantha L. Irwin et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Noninvasive vagus nerve stimulation as acute therapy for migraine
- (2018) Cristina Tassorelli et al. NEUROLOGY
- Non-Pharmacological Approaches for Migraine
- (2018) Francesca Puledda et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial
- (2018) Denise E Chou et al. CEPHALALGIA
- Barriers to Behavioral Treatment Adherence for Headache: An Examination of Attitudes, Beliefs, and Psychiatric Factors
- (2018) Yuka Matsuzawa et al. HEADACHE
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
- (2018) HEADACHE
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Lasmiditan is an effective acute treatment for migraine
- (2018) Bernice Kuca et al. NEUROLOGY
- Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary
- (2017) Ariane K. Kawata et al. HEADACHE
- A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine
- (2017) Sagar Munjal et al. JOURNAL OF HEADACHE AND PAIN
- Patients’ preferences for headache acute and preventive treatment
- (2017) Dimos D. Mitsikostas et al. JOURNAL OF HEADACHE AND PAIN
- Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
- (2017) Roger K. Cady et al. JOURNAL OF HEADACHE AND PAIN
- Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
- (2017) Daniel Serrano et al. JOURNAL OF HEADACHE AND PAIN
- National Trends in Direct Health Care Expenditures Among US Adults With Migraine: 2004 to 2013
- (2017) Amit D. Raval et al. JOURNAL OF PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Valery L Feigin et al. LANCET NEUROLOGY
- Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study
- (2017) Licia Grazzi et al. NEUROLOGICAL SCIENCES
- External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy
- (2017) Denise E. Chou et al. NEUROMODULATION
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Premonitory symptoms in migraine: A cross-sectional study in 2714 persons
- (2016) Katarina Laurell et al. CEPHALALGIA
- A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults
- (2016) Sagar Munjal et al. HEADACHE
- Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
- (2016) Sally Mannix et al. Health and Quality of Life Outcomes
- Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study
- (2016) Dawn C. Buse et al. MAYO CLINIC PROCEEDINGS
- Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- (2016) David M. Simpson et al. NEUROLOGY
- Drug safety in acute migraine treatment
- (2015) János Tajti et al. Expert Opinion On Drug Safety
- AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
- (2015) Stewart J. Tepper et al. HEADACHE
- The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
- (2015) Michael J. Marmura et al. HEADACHE
- Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2015) Dawn C. Buse et al. HEADACHE
- A pilot study of cognitive behavioural therapy and relaxation for migraine headache: a randomised controlled trial
- (2015) S. Cousins et al. JOURNAL OF NEUROLOGY
- Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
- (2015) R. B. Lipton et al. NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
- (2014) Roger K. Cady et al. HEADACHE
- Revised French guidelines for the diagnosis and management of migraine in adults and children
- (2014) Michel Lanteri-Minet et al. JOURNAL OF HEADACHE AND PAIN
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
- (2014) T. W. Ho et al. NEUROLOGY
- What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study
- (2014) Antonia F. H. Smelt et al. PLoS One
- Cutaneous allodynia as a predictor of migraine chronification
- (2013) Mark A. Louter et al. BRAIN
- A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
- (2013) Lars J Stovner et al. CEPHALALGIA
- Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans
- (2013) Daniel Serrano et al. HEADACHE
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Children and Adolescents
- (2013) Scott W. Powers et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial
- (2013) J. Schoenen et al. NEUROLOGY
- Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
- (2013) Daniel Serrano et al. VALUE IN HEALTH
- Cutaneous allodynia in patients with episodic migraine
- (2012) Hayat Güven et al. NEUROLOGICAL SCIENCES
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
- (2011) Christine L. Bagley et al. HEADACHE
- Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
- (2011) Dawn Buse et al. HEADACHE
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Biofeedback in headache: An overview of approaches and evidence
- (2010) F. ANDRASIK CLEVELAND CLINIC JOURNAL OF MEDICINE
- Validity and Reliability of the Migraine-Treatment Optimization Questionnaire
- (2009) RB Lipton et al. CEPHALALGIA
- A Comparison of Migraine Patients With and Without Allodynic Symptoms
- (2009) Jayantee Kalita et al. CLINICAL JOURNAL OF PAIN
- Medication overuse headache
- (2009) Zaza Katsarava et al. Current Neurology and Neuroscience Reports
- EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
- (2009) S. Evers et al. EUROPEAN JOURNAL OF NEUROLOGY
- Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2009) Julie Munakata et al. HEADACHE
- Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan
- (2008) PJ Goadsby et al. CEPHALALGIA
- Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study
- (2008) Marcelo E. Bigal et al. HEADACHE
- Cutaneous allodynia in the migraine population
- (2007) Richard B. Lipton et al. ANNALS OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started